PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China.\', \'Hunan Key Laboratory of Skin Cancer and Psoriasis, Changsha, China.\', \'Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, 87 XiangYa Road, Changsha, 410008, Hunan, China.\', \'Center for Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.\', \'Department of Respiratory and Critical Care Medicine, The Third Xiangya Hospital, Central South University, Changsha, China.\', \'Gerontology Center of Xiangya Hospital, Central South University, Changsha, China.\', \'The Respiratory Department, Xiangya Hospital, Central South University, 87 XiangYa Road, Changsha, 410008, Hunan, China. pinhuapan668@126.com.\', \'The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China. yh_927@126.com.\', \'Hunan Key Laboratory of Skin Cancer and Psoriasis, Changsha, China. yh_927@126.com.\', \'Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, 87 XiangYa Road, Changsha, 410008, Hunan, China. yh_927@126.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-020-04925-8
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33276811
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all